SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022 Medical Device Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Turning Point Therapeutics, Inc. , UB Bancorp , Sprague Resources LP , Gesher I Acquisition Corp. Pharmaceutical Investing
FDA APPROVES RIABNI , A BIOSIMILAR TO RITUXAN® , FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS Market News
Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC Pharmaceutical Investing
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights Medical Device Investing
Three-Year Data from Phase 3 CheckMate -9LA Trial Demonstrate Long-Term, Durable Survival Outcomes of Opdivo Plus Yervoy with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
